NO970731L - 2,3-dihydro-1-(2,2,2-trifluoretyl)-2-okso-5-fenyl-1H-1,4-benzodiazepiner - Google Patents
2,3-dihydro-1-(2,2,2-trifluoretyl)-2-okso-5-fenyl-1H-1,4-benzodiazepinerInfo
- Publication number
- NO970731L NO970731L NO970731A NO970731A NO970731L NO 970731 L NO970731 L NO 970731L NO 970731 A NO970731 A NO 970731A NO 970731 A NO970731 A NO 970731A NO 970731 L NO970731 L NO 970731L
- Authority
- NO
- Norway
- Prior art keywords
- benzodiazepine
- trifluoroethyl
- dihydro
- oxo
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29244794A | 1994-08-18 | 1994-08-18 | |
PCT/US1995/010500 WO1996005839A1 (en) | 1994-08-18 | 1995-08-17 | 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
Publications (2)
Publication Number | Publication Date |
---|---|
NO970731D0 NO970731D0 (no) | 1997-02-17 |
NO970731L true NO970731L (no) | 1997-02-17 |
Family
ID=23124712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970731A NO970731L (no) | 1994-08-18 | 1997-02-17 | 2,3-dihydro-1-(2,2,2-trifluoretyl)-2-okso-5-fenyl-1H-1,4-benzodiazepiner |
Country Status (24)
Country | Link |
---|---|
US (1) | US5658901A (ko) |
EP (1) | EP0776208B1 (ko) |
JP (1) | JPH10504570A (ko) |
KR (1) | KR970705395A (ko) |
CN (1) | CN1158568A (ko) |
AT (1) | ATE186463T1 (ko) |
AU (1) | AU692300B2 (ko) |
BG (1) | BG63032B1 (ko) |
BR (1) | BR9508608A (ko) |
CA (1) | CA2195974C (ko) |
CZ (1) | CZ285008B6 (ko) |
DE (1) | DE69513295T2 (ko) |
DK (1) | DK0776208T3 (ko) |
ES (1) | ES2139933T3 (ko) |
FI (1) | FI970668A (ko) |
GR (1) | GR3032592T3 (ko) |
HU (1) | HU220635B1 (ko) |
MX (1) | MX9701195A (ko) |
NO (1) | NO970731L (ko) |
NZ (1) | NZ291988A (ko) |
PL (1) | PL319104A1 (ko) |
RU (1) | RU2149161C1 (ko) |
SK (1) | SK282019B6 (ko) |
WO (1) | WO1996005839A1 (ko) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5631251A (en) * | 1995-06-07 | 1997-05-20 | Merck & Co., Inc. | 5-cyclopropyl-1,4 benzodiazepine-2-ones |
US5776930A (en) * | 1996-06-28 | 1998-07-07 | Merck & Company, Inc. | Pharmaceutical preparation |
JP2000510155A (ja) * | 1996-06-28 | 2000-08-08 | メルク エンド カンパニー インコーポレーテッド | 医薬製剤 |
US6635632B1 (en) | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
AU6320998A (en) | 1997-02-21 | 1998-09-09 | Bristol-Myers Squibb Company | Benzoic acid derivatives and related compounds as antiarrhythmic agents |
US6048877A (en) * | 1997-02-21 | 2000-04-11 | Bristol-Myers Squibb Company | Tetralone derivatives as antiarrhythmic agents |
US6262068B1 (en) | 1997-02-21 | 2001-07-17 | Bristol-Myers Squibb Company | Lactam derivatives as antiarrhythmic agents |
US5817658A (en) * | 1997-03-14 | 1998-10-06 | Merck & Company, Inc. | Method for treating Meniere's disease |
GB2328942A (en) * | 1997-09-05 | 1999-03-10 | Merck & Co Inc | Side chain synthesis for an antiarrythmic compound |
US6214823B1 (en) | 1997-10-17 | 2001-04-10 | Merck & Co., Inc. | Benzodiazepine derivatives as antiarrhythmic agents |
ES2148057B1 (es) * | 1998-01-05 | 2001-05-16 | Univ Murcia | Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3 |
US6664250B2 (en) | 1998-01-20 | 2003-12-16 | Bristol-Myers Squibb Co. | Lactam derivatives as antiarrhythmic agents |
US6958330B1 (en) | 1998-06-22 | 2005-10-25 | Elan Pharmaceuticals, Inc. | Polycyclic α-amino-ε-caprolactams and related compounds |
US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6528505B1 (en) | 1998-06-22 | 2003-03-04 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6774125B2 (en) * | 1998-06-22 | 2004-08-10 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6569851B1 (en) * | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6509331B1 (en) | 1998-06-22 | 2003-01-21 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
JP4410328B2 (ja) * | 1998-12-14 | 2010-02-03 | 久光製薬株式会社 | オキソクアゼパムの製造方法 |
GB0221923D0 (en) * | 2002-09-20 | 2002-10-30 | Arrow Therapeutics Ltd | Chemical compounds |
US20050192265A1 (en) * | 2003-03-20 | 2005-09-01 | Thompson Richard C. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
CU20090172A6 (es) | 2009-10-09 | 2011-10-05 | Facultad De Quimica Universidad De La Habana | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT75373B (en) * | 1981-08-12 | 1986-06-18 | Agripat Sa | Process for the preparation of tinted contact lenses |
DE3134672A1 (de) * | 1981-09-02 | 1983-03-17 | Boehringer Ingelheim KG, 6507 Ingelheim | Heterocyclische verbindungen, ihre herstellung und verwendung |
US4473575A (en) * | 1982-07-19 | 1984-09-25 | Ciba-Geigy Corporation | 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids |
DE3373469D1 (en) * | 1982-09-30 | 1987-10-15 | Merck & Co Inc | 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents |
DK151808C (da) * | 1982-11-16 | 1988-06-20 | Ferrosan As | Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater |
US4537885A (en) * | 1983-02-10 | 1985-08-27 | Ciba Geigy Corporation | Certain benzazocinone and benzazoninone derivatives |
US4470988A (en) * | 1983-02-10 | 1984-09-11 | Ciba-Geigy Corporation | Benzazocinone and benzazoninone derivatives, and their pharmaceutical use |
CA1252462A (en) * | 1984-01-19 | 1989-04-11 | Walter Hunkeler | Imidazodiazepine derivatives |
US4600534A (en) * | 1984-02-06 | 1986-07-15 | Ciba-Geigy Corporation | Process and intermediates for manufacture of 3-(5-amino-1-carboxypentylamino)-tetrahydro-1-benzazepin-2-one-1-acetic acid |
US5004741A (en) * | 1984-06-26 | 1991-04-02 | Merck & Co., Inc. | Methods of antagonizing CCK or gastrin with benzodiazepine analogs |
CA1332410C (en) * | 1984-06-26 | 1994-10-11 | Roger M. Freidinger | Benzodiazepine analogs |
US4820834A (en) * | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
US4692522A (en) * | 1985-04-01 | 1987-09-08 | Merck & Co., Inc. | Benzofused lactams useful as cholecystokinin antagonists |
US4847248A (en) * | 1986-12-23 | 1989-07-11 | Merck & Co., Inc. | 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists |
WO1989005812A1 (en) * | 1987-12-22 | 1989-06-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Thienodiazepine compounds and their medicinal use |
EP0322779A3 (en) * | 1987-12-29 | 1991-05-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzolactam compounds and pharmaceutical uses thereof |
US5166151A (en) * | 1988-03-25 | 1992-11-24 | Merck & Co., Inc. | 2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof |
US5324726A (en) * | 1989-12-18 | 1994-06-28 | Merck & Co., Inc. | Benzodiazepine analogs |
US5206234A (en) * | 1990-10-22 | 1993-04-27 | Merck & Co., Inc. | Benzolactam analogs as antagonists of cck |
US5220018A (en) * | 1991-04-10 | 1993-06-15 | Merck & Co., Inc. | Cholecystokinin antagonists |
CA2068355A1 (en) * | 1991-05-14 | 1992-11-15 | Mark S. Chambers | Benzodiazephine derivatives, compositions containing them and their use in therapy |
GB9116113D0 (en) * | 1991-07-25 | 1991-09-11 | Merck Sharp & Dohme | Therapeutic agents |
DE4125457A1 (de) * | 1991-08-01 | 1993-02-04 | Bayer Ag | Verfahren zur herstellung von n-substituierten lactamen |
CA2097285C (en) * | 1991-09-30 | 2000-03-14 | Yoichi Naka | Thienodiazepine compounds and their use |
WO1993007131A1 (en) * | 1991-10-10 | 1993-04-15 | Merck Sharp & Dohme Limited | Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors |
JPH07500589A (ja) * | 1991-10-24 | 1995-01-19 | メルク シヤープ エンド ドーム リミテツド | ベンゾジアゼピン誘導体、並びにコレシストキニン及び/又はガストリンレセプターのアンタゴニストとしての該誘導体の使用 |
WO1993008175A1 (en) * | 1991-10-24 | 1993-04-29 | Glaxo Group Limited | Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin |
US5428031A (en) * | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
DE69204040T2 (de) * | 1991-12-20 | 1996-03-28 | Merck Sharp & Dohme | 3-Phenylureido-1,4-Benzodiazepinone und ihre Verwendung als Cholecystokinin- oder Gastrinantagonisten. |
ZA93436B (en) * | 1992-01-24 | 1993-08-25 | Chugai Pharmaceutical Co Ltd | Benzopyran derivatives |
GB9203790D0 (en) * | 1992-02-21 | 1992-04-08 | Merck Sharp & Dohme | Therapeutic agents |
CA2130195A1 (en) * | 1992-03-16 | 1993-09-30 | Mark Gary Bock | Benzodiazepine derivatives, compositions containing them and their use in therapy |
IT1254558B (it) * | 1992-03-26 | 1995-09-25 | Mini Ricerca Scient Tecnolog | Composti a base di 3,4-diaril-(5h)-furan-2-one ad attivita' fungicida 3 |
GB9209518D0 (en) * | 1992-05-01 | 1992-06-17 | Merck Sharp & Dohme | Therapeutic agents |
US5360802A (en) * | 1992-05-11 | 1994-11-01 | Merck Sharpe & Dohme Ltd. | Benzodiazepine derivatives, compositions containing them and their use in therapy |
GB9218412D0 (en) * | 1992-08-28 | 1992-10-14 | Merck Sharp & Dohme | Therapeutic agents |
US5438055A (en) * | 1993-11-22 | 1995-08-01 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
US5439906A (en) * | 1993-11-22 | 1995-08-08 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
US5426185A (en) * | 1993-11-22 | 1995-06-20 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
US5428157A (en) * | 1993-11-22 | 1995-06-27 | Merck & Co., Inc. | 3-acylaminobenzodiazepines |
US5441950A (en) * | 1994-06-09 | 1995-08-15 | G. D. Searle & Co. | Substituted dibenzoxazepine and dibenzthiazepine carbamate compounds, pharmaceutical compositions and methods of use |
-
1995
- 1995-08-17 DE DE69513295T patent/DE69513295T2/de not_active Expired - Fee Related
- 1995-08-17 AT AT95930197T patent/ATE186463T1/de not_active IP Right Cessation
- 1995-08-17 ES ES95930197T patent/ES2139933T3/es not_active Expired - Lifetime
- 1995-08-17 HU HU9701275A patent/HU220635B1/hu not_active IP Right Cessation
- 1995-08-17 BR BR9508608A patent/BR9508608A/pt not_active Application Discontinuation
- 1995-08-17 DK DK95930197T patent/DK0776208T3/da active
- 1995-08-17 AU AU33667/95A patent/AU692300B2/en not_active Ceased
- 1995-08-17 MX MX9701195A patent/MX9701195A/es unknown
- 1995-08-17 EP EP95930197A patent/EP0776208B1/en not_active Expired - Lifetime
- 1995-08-17 JP JP8508203A patent/JPH10504570A/ja active Pending
- 1995-08-17 WO PCT/US1995/010500 patent/WO1996005839A1/en not_active Application Discontinuation
- 1995-08-17 RU RU97104124A patent/RU2149161C1/ru active
- 1995-08-17 PL PL95319104A patent/PL319104A1/xx unknown
- 1995-08-17 US US08/516,226 patent/US5658901A/en not_active Expired - Fee Related
- 1995-08-17 CN CN95195291A patent/CN1158568A/zh active Pending
- 1995-08-17 CA CA002195974A patent/CA2195974C/en not_active Expired - Fee Related
- 1995-08-17 CZ CZ97485A patent/CZ285008B6/cs not_active IP Right Cessation
- 1995-08-17 SK SK222-97A patent/SK282019B6/sk unknown
- 1995-08-17 KR KR1019970701009A patent/KR970705395A/ko not_active Application Discontinuation
- 1995-08-17 NZ NZ291988A patent/NZ291988A/en unknown
-
1997
- 1997-02-12 BG BG101227A patent/BG63032B1/bg unknown
- 1997-02-17 FI FI970668A patent/FI970668A/fi unknown
- 1997-02-17 NO NO970731A patent/NO970731L/no not_active Application Discontinuation
-
2000
- 2000-02-04 GR GR20000400287T patent/GR3032592T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2195974C (en) | 2000-12-05 |
ES2139933T3 (es) | 2000-02-16 |
BG63032B1 (bg) | 2001-02-28 |
DE69513295D1 (de) | 1999-12-16 |
HU220635B1 (hu) | 2002-03-28 |
WO1996005839A1 (en) | 1996-02-29 |
AU692300B2 (en) | 1998-06-04 |
AU3366795A (en) | 1996-03-14 |
BG101227A (en) | 1998-03-31 |
EP0776208A1 (en) | 1997-06-04 |
NO970731D0 (no) | 1997-02-17 |
SK22297A3 (en) | 1997-09-10 |
CZ48597A3 (en) | 1997-09-17 |
HUT76811A (en) | 1997-11-28 |
FI970668A0 (fi) | 1997-02-17 |
DE69513295T2 (de) | 2000-06-08 |
ATE186463T1 (de) | 1999-11-15 |
JPH10504570A (ja) | 1998-05-06 |
CZ285008B6 (cs) | 1999-04-14 |
US5658901A (en) | 1997-08-19 |
BR9508608A (pt) | 1997-12-30 |
KR970705395A (ko) | 1997-10-09 |
CA2195974A1 (en) | 1996-02-29 |
NZ291988A (en) | 1998-11-25 |
FI970668A (fi) | 1997-02-17 |
RU2149161C1 (ru) | 2000-05-20 |
EP0776208B1 (en) | 1999-11-10 |
SK282019B6 (sk) | 2001-10-08 |
PL319104A1 (en) | 1997-07-21 |
CN1158568A (zh) | 1997-09-03 |
EP0776208A4 (en) | 1997-12-29 |
MX9701195A (es) | 1997-05-31 |
DK0776208T3 (da) | 2000-05-01 |
GR3032592T3 (en) | 2000-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI970668A (fi) | 2,3-dihydro-1-(2,2,2-trifluorietyyli)-2-okso-5-fenyyli-1H-1,4-bentsodiatsepiinejä | |
ATE206409T1 (de) | N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h- benzo(b)(1,5)-diazepin-3-yl)-acetamide | |
NO800657L (no) | Ikke-ionogent roentgenkontrastmiddel. | |
LV12258A (lv) | Diaminociklobuten-3,4-dioni ka gludo muskulu relaksanti | |
PT83713A (de) | Neue 4-benzyl-1-(2h)-phthalazinon-derivate | |
ATE188472T1 (de) | 4-arylmethyloxymethyl piperidine als tachykinin antagonisten | |
ES2162907T3 (es) | 3-acilaminobenzacepinas. | |
EP0833819A4 (en) | N- (2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3-YL) -3-AMIDE | |
DE69610628D1 (de) | N-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide | |
DE69412016D1 (de) | Substituierte arylalkoxybenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
ES2194102T3 (es) | Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
SE8500107D0 (sv) | Neue 8alfa-acylaminoergoline | |
ECSP941124A (es) | 3-(heterociclico biciclicos) -6 fluoroalquiluracilos | |
DE69402935D1 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
ES2103794T3 (es) | Pirazolinas, pirazolidinas e hidrazinas artropodicidas. | |
ES2171306T3 (es) | Compuesto bajo la forma de isomero geometrico puro o de una mezcla de estos isomeros. | |
DK0625982T3 (da) | 4-Oxo- og 4H-imidazo(5,1-c)(1,4)benzoxaziner anvendelige som benzodiazepinreceptor-bindemidler | |
MX9306754A (es) | Bencilcarbamatos sustituidos con propiedades herbicidas. | |
DK428087A (da) | Dihydropyridin-5-phosphonsyre-cyclopropylenester | |
SE8700566L (sv) | Tetracykliska kinazolinoner | |
FI824155L (fi) | Foerfarande foer framstaellning av 3,7a-diazacyklohepta/j,k/fluoren | |
TR21967A (tr) | Organo-kalay bilesikleri | |
SE7904162L (sv) | 1,5-disubstituerad-1,2-dihydro-2h-1,4-benzodiazepin-2-oner | |
TH14957EX (th) | สารประกอบชนิดใหม่ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |